Open-label dose-extending placebos for opioid use disorder: a protocol for a randomised controlled clinical trial with methadone treatment

INTRODUCTION: More than 2 million individuals in the USA have an opioid use disorder (OUD). Methadone maintenance treatment is the gold standard of medication-based treatment for OUD, but high-dose methadone is associated with cardiotoxicity and respiratory complications, among other side effects. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Belcher, Annabelle M, Cole, Thomas O, Greenblatt, Aaron D, Hoag, Stephen W, Epstein, David H, Wagner, Michael, Billing, Amy S, Massey, Ebonie, Hamilton, Kristen R, Kozak, Zofia K, Welsh, Christopher J, Weintraub, Eric, Wickwire, Emerson M, Wish, Eric D, Kaptchuk, Ted J, Colloca, Luana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Addiction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596949/
https://www.ncbi.nlm.nih.gov/pubmed/31230007
http://dx.doi.org/10.1136/bmjopen-2018-026604

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596949/
https://www.ncbi.nlm.nih.gov/pubmed/31230007
http://dx.doi.org/10.1136/bmjopen-2018-026604

Ejemplares similares